Attach to Form 990 or Form 990-EZ.
Go to
www.irs.gov/Form990 for instructions and the latest information.
| (i) Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 10 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
|
Total |
||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2015 | (b) 2016 | (c) 2017 | (d) 2018 | (e) 2019 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. | ||||||
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf.... | ||||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 4 | Total. Add lines 1 through 3 | ||||||
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f).. | ||||||
| 6 | Public support. Subtract line 5 from line 4. | ||||||
Calendar year
(or fiscal year beginning in) ![]() |
(a) 2015 | (b) 2016 | (c) 2017 | (d) 2018 | (e) 2019 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | ||||||
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | ||||||
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | ||||||
| 11 | Total support. Add lines 7 through 10 | ||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2015 | (b) 2016 | (c) 2017 | (d) 2018 | (e) 2019 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | 0 | |||||
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose | 54,619,950 | 86,826,839 | 172,616,971 | 189,742,614 | 201,905,024 | 705,711,398 |
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513 ..... | 0 | |||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | 0 | |||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge | 0 | |||||
| 6 | Total. Add lines 1 through 5 | 54,619,950 | 86,826,839 | 172,616,971 | 189,742,614 | 201,905,024 | 705,711,398 |
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons | 0 | |||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | 0 | |||||
| c | Add lines 7a and 7b.. | ||||||
| 8 | Public support. (Subtract line 7c from line 6.) | 705,711,398 | |||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2015 | (b) 2016 | (c) 2017 | (d) 2018 | (e) 2019 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | 54,619,950 | 86,826,839 | 172,616,971 | 189,742,614 | 201,905,024 | 705,711,398 |
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | 839 | 14,056 | 6,034 | 32,226 | 65,512 | 118,667 |
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | 0 | |||||
| c | Add lines 10a and 10b. | 839 | 14,056 | 6,034 | 32,226 | 65,512 | 118,667 |
| 11 | Net income from unrelated business activities not included in line 10b, whether or not the business is regularly carried on. | 0 | |||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | 0 | |||||
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | 54,620,789 | 86,840,895 | 172,623,005 | 189,774,840 | 201,970,536 | 705,830,065 |
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 1-1/2% of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by .035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | ||
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
||
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | ||
| 4 Amounts paid to acquire exempt-use assets | ||
| 5 Qualified set-aside amounts (prior IRS approval required) | ||
| 6 Other distributions (describe in Part VI). See instructions | ||
| 7Total annual distributions. Add lines 1 through 6. | ||
|
8
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
||
| 9 Distributable amount for 2019 from Section C, line 6 | ||
| 10 Line 8 amount divided by Line 9 amount | ||
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2019 |
(iii) Distributable Amount for 2019 |
|
|---|---|---|---|---|
| 1 Distributable amount for 2019 from Section C, line 6 | ||||
|
2
Underdistributions, if any, for years prior to 2019 (reasonable cause required-- explain in Part VI). See instructions. |
||||
| 3 Excess distributions carryover, if any, to 2019: | ||||
| a From 2014....... | ||||
| b From 2015....... | ||||
| c From 2016....... | ||||
| d From 2017....... | ||||
| e From 2018....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2019 distributable amount | ||||
|
i
Carryover from 2014 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from 3f. | ||||
| 4Distributions for 2019 from Section D, line 7: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2019 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from 4. | ||||
|
5
Remaining underdistributions for years prior to 2019, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
6
Remaining underdistributions for 2019. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
7 Excess distributions carryover to 2020. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a Excess from 2015..... | ||||
| b Excess from 2016..... | ||||
| c Excess from 2017..... | ||||
| d Excess from 2018..... | ||||
| e Excess from 2019..... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|
| Software ID: | 17005038 |
| Software Version: | 2017v2.2 |
Attach to Form 990 or 990-EZ.
Go to www.irs.gov/Form990 for the latest information.
| Return Reference | Explanation |
|---|---|
| Form 990, Part III, Line 4d: Other Program Services Description | OTHER PROGRAM SERVICES 4: LPG employs many physicians and physician groups from Lifespans affiliated hospitals. Included among these various groups are the physicians working within the organization's OB/Gyn Associates group (OGA), the Cardiovacular Institute (CVI), neurosurgeons, pediatricians and plastic surgeons from Rhode Island Hospital (RIH), and Hospitalists from The Miriam Hospital (TMH). OTHER PROGRAM SERVICES 5: The LPG Department of Neurosurgery at RIH offers patient-focused, state-of-the-art clinical care in highly-equipped and modern facilities. Each of LPG's skilled surgeons has specific neurosurgical subspecialty expertise, including surgery for brain tumors and epilepsy, cerebrovascular surgery, skull-base surgery, radiosurgery, complex spine surgery, and pediatric neurosurgery. In addition to providing care to patients and families from all over New England and the nation, as well as from outside the United States, LPG surgeons are faculty members at The Warren Alpert Medical School of Brown University, where they conduct research as well as teach and mentor the next generation of neurosurgeons. Operating expenses and revenue for Neurosurgery during the fiscal year ended September 30, 2018 were $12,331,896 and $6,489,555, respectively.Ob-Gyn Associates (OGA) has been caring for women for more than 40 years. OGA is committed to bringing together intelligent, talented, and compassionate professionals in order to provide exceptional care for women based on the latest research, technological advances, and holistic approaches. With six locations in Rhode Island and Massachusetts, OGA was the first practice in Rhode Island to offer midwifery care and is one of only two practices in Rhode Island that offer deliveries in the Alternative Birthing Center of Women & Infants Hospital. OGA is also the only group in Rhode Island that has practice-wide protocols for high-risk obstetrics. OGA has the advantage of many highly trained and experienced providers with easy access to medical specialists at LPG's Women's Medicine Collaborative (WMC). OGA and WMC work in partnership with one another, consulting on difficult cases and assisting each other in numerous surgeries. Operating expenses and revenue for OGA during the fiscal year ended September 30, 2018 were $13,508,818 and $10,055,951, respectively. Operating expenses and revenue for WMC during the fiscal year ended September 30, 2018 were $4,110,099 and $2,221,756, respectively.The CVI was created in an effort to meet the demands of the changing health care environment and to enhance the level of cardiovascular care provided to the community. CVI includes approximately 55 cardiologists along with support staff at three ambulatory care centers and two comprehensive cardiac centers. This innovative program brought together the well-known cardiac programs of both RIH and TMH in 2012 and places a stronger emphasis on extending these programs into the community, where it is more convenient for patients to receive care. LPG's portion of CVI's program expenses consists primarily of CVI's expanded office-based services. CVI specialists work as a team across all disciplines, combining their expertise to provide an individualized treatment plan for each patient, whether the need is consultative, diagnostic, interventional, surgical, or rehabilitative. Operating expenses and revenue for this practice group during the fiscal year ended September 30, 2018 were $13,597,061 and $12,208,581, respectively. OTHER PROGRAM SERVICES 6: LPG Pediatrics:LPG's Pediatric practice group is comprised of a group of pediatricians and specialists who provide routine health check-ups, treat illnesses, lead immunization clinics, and staff Rhode Island Hospital's (RIH) pediatric division-Hasbro Children's Hospital. Operating expenses for this practice group directly charged to LPG during the fiscal year ended September 30, 2018 amounted to $21,408,828, representing primarily payroll and fringe benefit expenses funded by RIH. OTHER PROGRAM SERVICES 7: Operating expenses and revenue for the TMH Hospitalists during the fiscal year ended September 30, 2018 were $10,151,863 and $6,611,156, respectively. OTHER PROGRAM SERVICES 8: Operating expenses and revenue for the RIH Plastic Surgery Group during the fiscal year ended September 30, 2018 were $7,729,605 and $5,708,891, respectively.The remaining LPG revenue represents amounts funded by Lifespan's affiliated hospitals in order to bring LPG to a break-even point in its statement of operations. |
| Form 990, Part VI, Line 1a: Explanation of Delegated Broad Authority to Committee | Included among the LPG Board of Trustees are two Lifespan Designees (Designees), physicians designated by Lifespan Corporation (Lifespan) who are licensed to practice medicine in the State of Rhode Island and who serve at the pleasure of Lifespan. The Designees have the right, acting alone by concurrent approval of both Designees, to initiate action on and approve any of the following matters:(a) To approve and/or initiate the enumerated joint powers of the Trustees listed within LPG's bylaws, except to the extent that under Rhode Island law a greater number of Trustees of LPG is required to affirmatively approve a joint power action. To the extent that Rhode Island law requires a greater number of Trustees to make a recommendation or resolution on a joint power matter before undertaking such joint power action, all Trustees shall take such prior vote on such matter in accordance with the bylaws in the manner specified by concurrent approval of the Designees.(b) To initiate a joint power action listed in part (a) above, this ability can only be exercised by the Designees in the event of a Board deadlock on a matter first presented for action at a regular or special meeting of the Board of Trustees of LPG. (c) LPG shall cause the Designees' authority to approve and initiate actions to be reserved to LPG in the bylaws (or applicable organizational documents) of any subsidiary of which LPG is the sole or controlling member, partner, trustee, or stockholder, or that LPG otherwise owns or controls. |
| Form 990, Part VI, Line 2: Description of Business or Family Relationship of Officers, Directors, Et | Timothy J. Babineau, M.D., Chair, and Mary A. Wakefield, EVP/CFO, are board members of VNA Technicare, Inc. (VNA), a related for-profit corporation. Ms. Wakefield is also an officer of VNA. |
| Form 990, Part VI, Line 4: Description of Significant Changes to Organizational Documents | The bylaws of LPG have been amended so that the composition of the Board of Trustees shall be comprised of individuals nominated and selected from the LPG membership, having at least one year of employment with the organization, and being in good standing. Twelve of the Trustees shall be physician members in good standing. Seven of the Trustees shall have the respective designations or affiliations set forth below:- two physicians designated by Lifespan, who shall serve at the pleasure of Lifespan, each with vote;- the President of LPG, ex-officio with vote;- the Chief Financial Officer of Lifespan, or his/her designee, ex-officio without vote; and- Community Trustees, up to three individuals, external to LPG and Lifespan, with substantive business and leadership experience, preferably in the local healthcare industry, without vote.A Trustee term is three years long. The term begins at each Annual Meeting of LPG, during which certain Trustees vacate their seats, while new Trustees are presented and seated. Term - Initial Slate. An Initial Slate of twelve Trustees will be selected and nominated for approval by the Governance and Nominating Committee (G&NC) through the selection process outlined below. An Initial Slate Trustee will be randomly chosen to have an initial term of either one, two, or three years. As the Initial Slate of Trustees serves out their terms after one, two, and three years, the G&NC will nominate and select candidates for a slate of four additional Trustees. Each Initial Slate Trustee may be appointed to serve two additional consecutive terms of three years each.Term After Year 3. After the twelve Initial Slate Trustees have served at least their initial term, the G&NC will annually nominate and select a slate of four additional Trustees. Each Trustee then appointed will serve a three-year term. Term Limits. A Trustee may only be appointed to serve a maximum of three consecutive terms. Upon the completion of three terms, the Trustee shall wait one year before once again being qualified for a reappointment to the Board. All Trustees shall hold office until the expiration of their respective terms or until their respective successors are duly elected and qualified, or until they sooner die, resign, are removed, or become disqualified. An appointed Trustee shall cease to be a Trustee if he/she does not have an active Medical Staff appointment and clinical privileges at any Lifespan hospital. Upon the occurrence of a mid-term vacancy, a new Trustee shall be appointed to finish serving that term. Afterwards that trustee may, in their own right, be appointed to serve up to three consecutive terms.Lifespan Designees. The Lifespan Designees shall serve until their successors are elected or appointed, as the case may be. The Lifespan Designees shall serve at the pleasure of Lifespan, or until such person sooner dies, resigns, is removed, or becomes disqualified. Lifespan shall consult with the Board of Trustees prior to any removal, change and/or reappointment of any Lifespan Designee, provided, however, that in no event shall the authority of Lifespan to appoint the Lifespan Designees be limited by or subject to approval of the Board of Trustees of LPG.Ex-Officio Trustees. A person serving as a Trustee in an ex-officio capacity shall serve as long as such person holds the position that qualifies such person to serve as a Trustee. Such person shall cease to be an ex-officio Trustee upon ceasing to hold the position that qualifies the person to be a Trustee, and any successor to such position, whether acting, interim, or permanent, shall immediately succeed such person as Trustee.Community Trustee. A person serving as a Community Trustee shall serve terms equal in length to an LPG Trustee, with the same maximum number of consecutive terms. |
| Form 990, Part VI, Line 11b: Form 990 Review Process | The preparation and filing of the Form 990 and supporting schedules is the responsibility of the Executive Vice President & Chief Financial Officer (EVP/CFO) and Lifespan's Finance Department, with review by Lifespan's tax advisors, KPMG LLP (KPMG). The Form 990 is prepared by the accounting staff upon completion of Lifespan's annual independent audit and reviewed by the Corporate Services Tax Compliance Manager, the Director of Finance, and the Vice President of Finance - Corporate Services. The Form 990 is forwarded to KPMG for further review. KPMG provides the Tax Compliance Manager with any recommended changes which are reviewed, and if agreed upon, are incorporated into the return. The draft Form 990 is then provided to the EVP/CFO for final management review. Prior to filing the return with the Internal Revenue Service, a copy of the entire form is sent to LPG's Board of Trustees in advance of its next Board meeting, at which the EVP/CFO discusses highlights of the Form. All questions and concerns of the members of the Board are addressed by the EVP/CFO and incorporated into the Form 990 when appropriate. Once the Form 990 is complete and ready to be filed, the members of the Board are notified via email that a copy of the final version of the Form 990 is accessible through a password-protected website portal. The EVP/CFO is authorized to file the Form 990. |
| Form 990, Part VI, Line 19: Other Organization Documents Publicly Available | Lifespan currently makes its annual and quarterly consolidated financial statements available to the public via DAC (Digital Assurance Certification, LLC), a disclosure dissemination agent for issuers of tax-exempt bonds which electronically posts and transmits Lifespan's financial information to repositories and investors alike. Copies of LPG's Articles of Incorporation, Bylaws, and Conflict of Interest Policy are available upon request from the office of the Lifespan EVP/CFO, either in person or by mail. |
| Other Changes In Net Assets Or Fund Balances - Other Increases | Change in funded status of pension plan = $1254000 |
| Form 990, Part I, Line 1: | Lifespan Physician Group (LPG) primarily serves hospitals affiliated with Lifespan Corporation. Additionally, it is LPG's mission to promote and advance medical research, education and training in medicine, medical-related sciences, and clinical practice. |
| Form 990, Part VI, Section B, Line 12c: | Lifespan Corporation has a Conflict of Interest Policy that is applicable to all affiliates, including LPG, and administered by Lifespan's Corporate Compliance Department as follows: Each designated person subject to Lifespan's conflict of interest policy is required to provide Lifespan with an initial disclosure statement and thereafter an annual statement attesting that: (i) the designated person has read and is familiar with this policy, and (ii) the designated person and, to the best of his/her knowledge, family members, have not in the past engaged in, are not presently engaging in, or plan to engage in, any activity which contravenes this policy.If, at any time during the course of employment or association, a designated person has reason to believe that an existing or contemplated activity may contravene this policy, the person shall submit a full written description of the activity to the Lifespan Compliance Officer or the Office of the General Counsel to seek a determination as to whether the contemplated activity does or does not contravene this policy. This requirement shall be acknowledged as part of the annual performance evaluation process. If the activity in question involves either the Chief Executive Officer, the Senior Vice President and General Counsel, or a Trustee, a full written disclosure must be made to, and a determination sought from, the Chairman of the Board of Directors of Lifespan Corporation.Annually, the Lifespan Compliance Officer shall review and report to the Lifespan Executive Corporate Compliance Committee and to the Lifespan Audit and Compliance Committee on the administration of this policy.Failure on the part of any designated person to comply with this policy, including failure to submit in a timely fashion the conflict of interest disclosure statement, will be grounds for removal from his/her position and/or termination of his/her employment with Lifespan. |
| Form 990, Part VI, Section B, Lines 15 a&b: | The following applies to Lifespan and all of its affiliates, including LPG:EXECUTIVE COMPENSATIONLifespan's executive compensation philosophy balances appropriate stewardship of resources and the need to be competitive in recruiting and retaining talented individuals. It incorporates market-competitive and performance-related principles, and covers the President and CEO of Lifespan as well as other officers, senior management, and key employees. Lifespan's executive compensation program complies both with law and with contemporary ethical norms, and is administered consistent with the organization's tax-exempt status under Section 501(c)(3) of the Internal Revenue Code (IRC) and the avoidance of transactions subject to intermediate sanctions under Section 4958 of the IRC. Executive compensation is also administered consistent with Lifespan's Corporate Compliance Policy on Excess Benefit Transactions.The Compensation Committee of the Lifespan Corporation Board of Directors (the Committee), comprised of disinterested Lifespan Board members, is responsible for diligent oversight of executive compensation to ensure compliance with IRC requirements. Its duties include:* Approving eligibility for participation in the executive compensation program * Approving changes in compensation for existing executive participants * Approving guidelines, such as salary ranges and contract terms, on appropriate levels of compensation for other key employees* Approving new, and modifying or terminating existing, executive compensation plans including, but not limited to, annual incentive and executive benefit plans* Approving performance objectives associated with Lifespan's annual incentive plan, including measuring points, and using audited actual performance relative to these objectives as a precondition to approving the payment of any awards under the plan* Authorizing periodic performance benchmark studies to be conducted for purposes of assessing Lifespan's performance within the healthcare industry and the degree to which total remuneration levels at Lifespan are generally commensurate with Lifespan performance relative to healthcare industry performance* Conducting an annual performance review of Lifespan's Chief Executive Officer. The Chair of the Committee conducts and documents this review, based on his/her observations and interpretation of feedback from members of the Board of Directors.* Selecting and engaging qualified, independent, third-party compensation valuation consultants that the Committee charges with rendering opinions with respect to the reasonableness and comparability of compensation as well as the comparative organizations against which compensation is assessed, in accordance with relevant sections of the IRC and Lifespan's executive compensation philosophy.Lifespan's Chief Executive Officer works closely with the Committee to make recommendations on the above topics and keep the Committee informed about contemplated compensation changes for executives and other key employees, as well as candidates for these roles. The CEO also provides periodic updates to the Committee regarding Lifespan's performance relative to compensation-related performance objectives. The Committee's deliberations and actions are documented in minutes prepared for each meeting.PROCESS FOR DETERMINING COMPENSATION Valuation of Total Cash and Total Remuneration: No less frequently than annually, the Committee receives and reviews a total cash compensation valuation of all existing executive compensation program participants prepared by its independent compensation consultant. Annually, the Committee also receives and reviews a total remuneration valuation of all existing executive compensation participants.Base Salary Actions: The CEO recommends any salary adjustments for participants in the executive compensation program, using the results of the valuation study and his/her assessment of individual performance or other pertinent information, for the Committee's consideration.New Participants in Executive Compensation Program: With respect to compensation offers for individuals expected to participate in the executive compensation program, certain members of the Lifespan CEO's Council work with the Committee's independent compensation consultant or rely on information previously provided by the consultant to establish a range of reasonable cash compensation within which recruitment is expected to conclude with acceptance of a reasonable compensation offer. |
| Form 990, Part XII, Line 2: | While LPG did not produce an audited financial statement as of and for the fiscal year ended September 30, 2018, it was included in Lifespan Corporation's (Lifespan) audited consolidated financial statements, in which one column is used for LPG individually. There are no regulatory or creditor stipulations which require the preparation of a separate audited financial statement for LPG.The Lifespan Audit and Compliance Committee assumes responsibility for oversight of the audit of Lifespan Corporation's consolidated financial statements and the selection of Lifespan Corporation's independent accountant. |
| Software ID: | 17005038 |
| Software Version: | 2017v2.2 |